You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (31) |
Back to Search
incidence and influencing factors of rituximab-related hypersensitivity in inpatients: a case-control study
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-HPS-023
- By: LIU, Siyuan (Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China, China)
- Co-author(s): Liu Siyuan: , Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China
Guo Daihong: , Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China
Wang Weilan: , Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China
Yao Chong: , Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China
Zhu Man: , Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China - Abstract:
Background
The increasing incidence of rituximab-related hypersensitivity (RRH) reactions has affected the application of rituximab as a first-line therapy. However, evidence of RRH reactions in the Chinese population is limited.Purpose
This study aimed to understand the clinical application of rituximab and the occurrence characteristics of RRH.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026